Research analysts at JMP Securities started coverage on shares of Organovo Holdings Inc (NYSEMKT:ONVO) in a report released on Dec. 18. The firm set a “market perform” rating on the stock. Organovo Holdings Inc (NYSEMKT:ONVO) stock opened at $10.80 in last session, and closed at $10.18, while the day range of ONVO stock is $9.86 – $10.90. The stock showed a positive weekly performance of 9.70%.
Sarepta Therapeutic (NASDAQ:SRPT) was downgraded by equities research analysts at Citigroup Inc. from a “neutral” rating to a “sell” rating in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. Sarepta Therapeutics Inc (NASDAQ:SRPT) stock opened at $19.21, in last session and closed at $18.77, by losing -8.17%. The 52 week range of the stock is $12.12 – $55.61. Company’s market capitalization is $705.42 billion.
A number of research firms have recently commented on Keryx Biopharmaceuticals (NASDAQ:KERX). Analysts at JPMorgan Chase & Co. reiterated a “positive” rating on shares of Keryx Biopharmaceuticals in a research note to investors on Thursday, November 7th. Separately, analysts at Brean Capital reiterated a “buy” rating on shares of Keryx Biopharmaceuticals in a research note to investors on Tuesday, November 5th. Keryx Biopharmaceuticals (NASDAQ:KERX) stock decreased -5.22% and finished the last session at $12.16. The EPS of the stock remained -0.45. Company’s market capitalization is $1.00 billion.
BG Medicine, Inc. (NASDAQ:BGMD) trimmed early losses on profit-taking after it climbed 37.74% Friday as the final determination of the 2014 Medicare national limitation amount for the company’s galectin-3 blood test at the amount of a crosswalked test whose 2014 national limitation amount is $30.01 was set to apply effective January 1, 2014. BG Medicine, Inc. (NASDAQ:BGMD) stock opened the session at $1.48, and closed the session at $1.40. The 52 week range of the stock remained $0.55 – $2.84 and the day range was $1.26 – $1.48.